Contract Dose Manufacturing Industry by the Numbers - Composition, Size, Market Share and Outlook - 2020 Edition

5.1 Definition of the Dose CMO Universe
5.2 Industry Demographics

7.1 Dose Manufacturing

8.1 Characteristics of the Largest CMOs

9.1 The Outlook for the Dose CMO Industry

10.1 Methodology for Market Size & Growth Estimates
10.2 CMO Classifications
10.3 Industry Cost of Goods
10.4 Bibliography
10.5 Primary Research-Key Opinion Leaders in this Report
10.6 About the Authors
10.7 Contact
10.8 Disclaimer

Table 1: Summary of CMO Facility Acquisition of Dose Facilities Activity, 2013-2019
Table 2: CMO Acquisitions of Dose Manufacturing Facilities, 2019
Table 3: Dedicated CMO Acquisitions of Companies with Commercial Dose Capabilities, 2019
Table 4: PE Investments in the Dose CMO Industry, 2013-2019
Table 5: Count of CMO Facilities that Offer Other Services, by Company Revenue Tier
Table 6: Revenue Composition and Strategic Orientation of Leading CMOs, 2019
Table 7: Geographical Reach of Dose CMO Universe, 2020

Figure 1: Geographic Reach of the Dose CMO Universe, 2019
Figure 2: Geographic Distribution of Commercial Dose Facilities, 2019
Figure 3: Geographic Distribution of Commercial Dose Injectable Facilities, 2019
Figure 4: CMO Count by Dose Revenue Tiers, 2019
Figure 5: Dose CMO Market Size by Revenue, 2009-2019
Figure 6: Components of Growth for Dose CMOs, 2018-2019
Figure 7: Dose CMO Dosage Form Revenue Segments in 2019 ($B)
Figure 8: Dose Facility Locations of $0-12M Annual Revenue Tier CMOs
Figure 9: Dosage Forms Manufactured for $0-12M Annual Revenue Tier CMO Facilities
Figure 10: Dose CMO Industry Market Share by Company Revenue Tier, 2019
Figure 11: Contract Service Agreements for Commercial-Scale API Manufacturing, 2018-2020
Figure 12: Bio/Pharma Services Sector Performance
Figure 13: Revenue Growth for Public CMOs
Figure 14: Small Cap Dose Outsourcing Propensity, 2010-2019
Figure 15: Outsourcing of Orphan NMEs, 2010-2019